Adding a Medicine to WHO Model List of Essential Medicines
| dc.contributor.author | Kishore, Sandeep | |
| dc.contributor.author | Herbstman, Benjamin | |
| dc.date.accessioned | 2009-03-28T12:47:05Z | |
| dc.date.available | 2009-03-28T12:47:05Z | |
| dc.date.issued | 2009-03 | |
| dc.description.abstract | Although the concept of essential medicines is not new, the processes that lead to placement of these medicines on the World Health Organization Model List of Essential Medicines are not well understood. Here, we describe the process by which we added a class of drugs, statins, to the Model List to help combat the growing global epidemic of cardiovascular disease. | en_US |
| dc.description.sponsorship | This work was supported by National Institutes of Health Medical Scientist Training Program grant GM07739 and the Paul and Daisy Soros Fellowship to S.P.K. The funders were not involved in the decision to submit the article or in its preparation. | en_US |
| dc.identifier.citation | Clin. Pharmacol. Ther. 2009. March; 85(3): 237-9 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1813/12139 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Nature Publishing Group; Clinical Pharmacology & Therapeutics | en_US |
| dc.subject | Essential Medicines | en_US |
| dc.subject | WHO Model List of Essential Medicines List | en_US |
| dc.subject | Statins | en_US |
| dc.title | Adding a Medicine to WHO Model List of Essential Medicines | en_US |
| dc.type | article | en_US |
Files
Original bundle
1 - 1 of 1